Trials / Enrolling By Invitation
Enrolling By InvitationNCT06455566
Vascular Access for Minimally-invasive Leadless Pacemaker Implantation Through the Right Jugular routE
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Leadless pacemakers (LP) are associated with a lower risk of revision compared with transvenous pacemakers. However, LPs implantation is associated with a 0.6% risk of complication at the femoral vein puncture site (e.g. arteriovenous fistula, haemorrhage, pseudoaneurysm, etc.). As a consequence, the need for prolonged in-hospital monitoring after LP implantation though the right femoral (RF)vein is a barrier to same-day discharge. Recently, right internal jugular (RIJ) vein access has emerged an alternative to right RF vein access for LP implantation (with a regulatory approval for MEDTRONIC Micra LP). The aims of this registry are the following : * evaluate the feasibility of RIJ access for LP implantation; * confirm the acute and chronic safety of RIJ access for LP implantation; * compare RIJ to RF (historical cohort) vein access regarding procedural characteristics and outcomes; * evaluate the feasibility of same-day discharge avec LP implantation through the RIJ vein.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Leadless pacemaker implantation through right internal jugular vein | Leadless pacemaker implantation through right internal jugular vein |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2026-05-01
- Completion
- 2027-05-01
- First posted
- 2024-06-12
- Last updated
- 2025-03-26
Locations
13 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06455566. Inclusion in this directory is not an endorsement.